HIV-1 p24 May Persist During Long-Term Highly Active Antiretroviral Therapy, Increases Little During Short Treatment Breaks, and Its Rebound After Treatment Stop Correlates With CD4+ T Cell Loss (Q59316498)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | HIV-1 p24 May Persist During Long-Term Highly Active Antiretroviral Therapy, Increases Little During Short Treatment Breaks, and Its Rebound After Treatment Stop Correlates With CD4+ T Cell Loss |
article |
Statements
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss (English)
Huldrych Günthard
Swiss HIV Cohort Study
Beda Joos
Marek Fischer
Zuzana Tomasik
Luc Perrin
Pietro Vernazza
Jürg Böni
Sabine Yerly
Manuel Battegay
Hansjakob Furrer
Enos Bernasconi
Bernard Hirschel
1 November 2005